Investment Strategy

Answering top questions on China

The US-China relationship has entered a familiar rhythm – high-profile summitry between the two, incremental deliverables to keep the relationship just somewhat stable, and unresolved structural tensions running just beneath the surface. Last week's meeting between President Trump and President Xi captured that dynamic well: a two-month truce extension, a handful of symbolic announcements, and a shared willingness to keep talking – with two more meetings planned over the coming year. Unfortunately, there was little substantive improvement on the issues that actually matter most to markets in the long-term, especially on technology and tariffs. The absence of escalation was itself the outcome, and that mutual leverage – US chip controls on one side, Chinese rare earths on the other – is sustaining a fragile equilibrium that could still tip over as dependencies decline over time.

Against this backdrop, China's own economic story is one of intensifying imbalances which remain vulnerable to pullbacks in AI and its relationship with the US. Exports and the AI supply chain remain bright spots, yet domestic activity across consumption, capex and housing continues to soften. Despite that, the renminbi is priced to strengthen to some of its strongest levels in over a decade, creating an interesting opportunity for investors. In this week’s Asia Strategy Focus, we address some of clients’ most asked questions on China, and look at potential investment opportunities in China’s currency and equities.

1) What are the main takeaways from the summit between President Trump and President Xi?

The summit was short on substance but long on symbolism – but the symbolism matters. No major breakthroughs were expected, and none materialized. The announced items were incremental and optics-focused rather than regime-changing: a two-month extension of the trade truce through 10 January 2027 (spanning the upcoming APEC and G20 leaders' meetings), released product lists for tariff reductions on $30 billion of non-sensitive goods, a Chinese commitment to import at least 10 million metric tons of US coal in 2027–28, and a new AI incident-communication hotline. The most market-relevant result was what did not happen: the summit acted as a circuit breaker against near-term escalation rather than a catalyst for optimism. This baseline predictability still matters especially compared to the risk of directional lurches in prior cycles. The leader-to-leader optics and rapport that has been built between them may not resolve structural conflict, but it can lower the probability of accidental escalation in the near-term. With both leaders signaling intent to meet again, it fosters a "keep talking" framework that anchors expectations.

2) What points of leverage does the US have, and what does China have?

The relationship is best understood as one of mutual vulnerability. US leverage is concentrated at the top of the technology stack – advanced semiconductors, manufacturing equipment, and export controls governing access to them. Tariffs remain a lever, but tech controls are more strategically binding because they constrain capabilities. China's leverage lies where it has scale, processing capacity and ecosystem depth – rare earths and magnets being the clearest example; reconstituting those supply chains takes years of capex and coordination – a significant challenge that the US is trying to tackle.

Crucially, this leverage is time-limited – China is racing to reduce its reliance on US chips while the US diversifies away from Chinese materials – so the mutual restraint that supports the current fragile equilibrium may erode as dependencies fall.

3) Can China exert pressure through the US Treasury market?

This is a recurring client question, and the honest answer is: not easily. Despite declines in the official SAFE holdings held with the Fed, China has been holding more Treasuries through international custodians such as Euroclear and Clearstream, making the overall decline in Treasury holdings relatively small. This also means China retains a large position in US Treasuries and can theoretically use it to exert pressure through selling those securities in the market. But two problems make it a poor weapon of choice. First, China runs the risk of self-inflicting loses because selling in size pushes yields up and prices down, marking down the very reserves China still holds in size. Second, there is a scale and absorption problem – sales large enough to move markets become disorderly and costly to execute, and it is not clear the medium-term impact would necessarily remain asymmetric against the US.

China’s treasury holdings have not declined and are still significant

$USD, billions

Source: NBS, U.S. Treasury TIC, Haver Analytics. Data as of August 2026. 

4) What role can China play in the Middle East conflict, especially through the oil market?

China is the world’s largest crude oil importer and is regarded as the "price-setting barrel" in the global oil market. Since March it has acted as a short-term shock absorber – sharply cutting crude imports and running down commercial inventories (refined-product stocks sit near a two-year low) rather than tapping strategic reserves. That behavior has helped cap price spikes during the conflict. The risk is that the cushion flips into a tailwind: once inventories fall below comfortable operating levels, restocking becomes necessary, potentially adding incremental demand just as the market already carries a geopolitical risk premium – supporting higher-for-longer oil pricing. However, price sensitivity, refinery flexibility and ample strategic reserves could keep the pace of restocking at a gradual rate.

Refined product inventory is at a 2-year low

China refined oil products inventory level: independent refinery, 10,000 tons

Source: Oilchem. Wind Information. Data as of September 24, 2026. 

5) With uncertain US-China relations and the Middle East war as backdrop, what is China's economic outlook?

We remain cautious on the overall China macroeconomic outlook. The key trend of “imbalance” has intensified: strong exports and a muted domestic economy, resulting in an even more “K-shaped” growth profile. Exports have continued to be the bright spot – with exceptional strength in non-US demand and China's growing position as a key supplier in the AI supply chain. But the bar to sustain that pace is high: the tariff truce with the US is fragile and trade frictions with Europe and some emerging markets are rising, leading to an increasingly vulnerable export outlook. Domestically, activity has softened across capex, consumption and housing, with local-government fiscal consolidation – tied to ongoing efforts to clean up legacy hidden debt – resulting in drags on public investment. Overall, we see subdued domestic growth with policy support likely skewed toward monetary fine-tuning and gradual fiscal catch-ups, rather than a meaningful stimulus.

The economy remains unbalanced with exports driving most of the growth

Economic activity level, indexed September 2019 = 100

Source: China National Bureau of Statistics, China Customs, Haver Analytics. J.P. Morgan Private Bank. Data as of August 2026.  

6) Has the RMB’s best run been and gone?

The renminbi's year-to-date strength reflects a guided, smooth appreciation – supported by export strength and the US-China trade truce, with the People’s Bank of China (PBOC) tolerating a controlled upward path. We maintained a bullish view for much of this year, but now believe the appreciation cycle is approaching maturity.  With the Federal Reserve and most major central banks tightening policy while the PBOC continues to ease, policy divergence has widened, resulting in a more negative carry backdrop for the yuan. Meanwhile, exceptionally strong export growth is likely to moderate given a high base and a potential pickup in broader trade frictions. The PBOC has also recently ramped up pushback against one-sided appreciation.

The PBoC is pushing back on the pace of RMB appreciation

PBoC fixing error, pips

Source: Exante Data China Flow Analytics, CFETS, Macrobond. Data as of September 21, 2026. Outlooks and past performance are no guarantee of future results. It is not possible to invest directly in an index. 
With interest rate differentials widening, the 2-year USDCNH forward is trading below 6.30, among the lowest levels since the 2015 renminbi reform. This has improved the risk-reward for investors looking to hold long USDCNH positions for carry. Risks remain, including renewed US dollar weakness and a reversal of the interest rate divergence currently priced into markets. However, for investors with existing CNH assets or revenue streams seeking to hedge currency exposure, or those expecting to convert CNH into USD over the medium term, current levels offer an attractive opportunity to lock in favorable exchange rates.

Forward levels are at some of their lowest levels since the 2015 renminbi reform

USDCNH spot and forward levels

Source: Bloomberg Finance L.P., J.P. Morgan Private Bank. Data as of September 28, 2026. 

7) Chinese equities have underperformed this year — where are the investment opportunities?

We see a limited opportunity set in Chinese equities focused on tech innovation amid a weaker domestic fundamental backdrop. Chinese equities have lagged sharply this year: the MSCI China Index is down ~11% year-to-date and the onshore CSI 300 off ~4%, against the MSCI World which is up ~12% and broader EM equities up ~24%. Consistent with that backdrop, we downgraded our outlook on offshore China to neutral following the >10% rebound in the summer, reflecting a softer macro picture, limited earnings revision momentum, less compelling valuations vs regional peers, and potential liquidity implications from the new tax collection policy, and we are reassessing the outlook for onshore China as well. We remain highly selective, with a preference for tech companies positioned for innovation and focused on structural growth tied to AI adoption, AI infrastructure, semiconductor localization and industrial automation thematics. For investors, we re-iterate a preference for other regions within Asia such as Korea and Taiwan over China.

IMPORTANT INFORMATION

All market and economic data as of September, 2026 and sourced from Bloomberg Finance L.P. and FactSet unless otherwise stated.

For illustrative purposes only. Estimates, forecasts and comparisons are as of the dates stated in the material.

This document may also have been made available in a different language, at the recipient’s request, and for convenience only. Notwithstanding the provision of a convenience copy, the recipient re-confirms that they are fully conversant and has full comprehension of the English language. In the event of any inconsistency between such English language original and the translation, including without limitation in relation to the construction, meaning or interpretation thereof, the English language original shall prevail.

Indices are not investment products and may not be considered for investment. 

For illustrative purposes only. This does not reflect the performance of any specific investment scenario and does not take into account various other factors which may impact actual performance.

Past performance is not a guarantee of future returns and investors may get back less than the amount invested.

This material is for information purposes only, and may inform you of certain products and services offered by private banking businesses, part of JPMorgan Chase & Co. ("JPM"). Products and services described, as well as associated fees, charges and interest rates, are subject to change in accordance with the applicable account agreements and may differ among geographic locations. Not all products and services are offered at all locations.

GENERAL RISKS & CONSIDERATIONS

Any views, strategies or products discussed in this material may not be appropriate for all individuals and are subject to risks. Investors may get back less than they invested, and past performance is not a reliable indicator of future results. Asset allocation/diversification does not guarantee a profit or protect against loss. Nothing in this material should be relied upon in isolation for the purpose of making an investment decision. You are urged to consider carefully whether the services, products, asset classes (e.g. equities, fixed income, alternative investments, commodities, etc.) or strategies discussed are suitable to your needs. You must also consider the objectives, risks, charges, and expenses associated with an investment service, product or strategy prior to making an investment decision. For this and more complete information, including discussion of your goals/situation, contact your J.P. Morgan team.

NON-RELIANCE

Certain information contained in this material is believed to be reliable; however, JPM does not represent or warrant its accuracy, reliability or completeness, or accept any liability for any loss or damage (whether direct or indirect) arising out of the use of all or any part of this material. No representation or warranty should be made with regard to any computations, graphs, tables, diagrams or commentary in this material, which are provided for illustration/reference purposes only. The views, opinions, estimates and strategies expressed in this material constitute our judgment based on current market conditions and are subject to change without notice. JPM assumes no duty to update any information in this material in the event that such information changes. Views, opinions, estimates and strategies expressed herein may differ from those expressed by other areas of JPM, views expressed for other purposes or in other contexts, and this material should not be regarded as a research report. Any projected results and risks are based solely on hypothetical examples cited, and actual results and risks will vary depending on specific circumstances. Forward-looking statements should not be considered as guarantees or predictions of future events.

Nothing in this document shall be construed as giving rise to any duty of care owed to, or advisory relationship with, you or any third party. Nothing in this document shall be regarded as an offer, solicitation, recommendation or advice (whether financial, accounting, legal, tax or other) given by J.P. Morgan and/or its officers or employees, irrespective of whether or not such communication was given at your request. J.P. Morgan and its affiliates and employees do not provide tax, legal or accounting advice. You should consult your own tax, legal and accounting advisors before engaging in any financial transactions.

We address clients’ most asked questions on China, from the Trump-Xi meeting to China’s macro outlook, and consider potential investment opportunities in China’s currency and equities.

You may also like

Sep 17, 2026
Is Australia at an Inflection Point?

Experience the full possibility of your wealth

We can help you navigate a complex financial landscape. Reach out today to learn how.

Contact us
Up Next
Investment Strategy

1 minute read

One economy, two markets, one message

Trending Insights

    LEARN MORE About Our Firm and Investment Professionals Through FINRA BrokerCheck

     

    To learn more about J.P. Morgan’s investment business, including our accounts, products and services, as well as our relationship with you, please review our J.P. Morgan Securities LLC Form CRS and Guide to Investment Services and Brokerage Products. 

     

    JPMorgan Chase Bank, N.A. and its affiliates (collectively "JPMCB") offer investment products, which may include bank-managed accounts and custody, as part of its trust and fiduciary services. Other investment products and services, such as brokerage and advisory accounts, are offered through J.P. Morgan Securities LLC ("JPMS"), a member of FINRA and SIPC. Insurance products are made available through Chase Insurance Agency, Inc. (CIA), a licensed insurance agency, doing business as Chase Insurance Agency Services, Inc. in Florida. JPMCB, JPMS and CIA are affiliated companies under the common control of JPMorgan Chase & Co. Products not available in all states.

     

    Please read the Legal Disclaimer (for J.P. Morgan regional affiliates and other important information) and the relevant deposit protection schemes.

     

    DEPOSIT PROTECTION SCHEME 存款保障計劃   JPMorgan Chase Bank, N.A.是存款保障計劃的成員。本銀行接受的合資格存款受存保計劃保障,最高保障額為每名存款人HK$500,000。   JPMorgan Chase Bank N.A. is a member of the Deposit Protection Scheme. Eligible deposits taken by this Bank are protected by the Scheme up to a limit of HK$500,000 per depositor.
    INVESTMENT AND INSURANCE PRODUCTS ARE: • NOT FDIC INSURED • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY • NOT A DEPOSIT OR OTHER OBLIGATION OF, OR GUARANTEED BY, JPMORGAN CHASE BANK, N.A. OR ANY OF ITS AFFILIATES • SUBJECT TO INVESTMENT RISKS, INCLUDING POSSIBLE LOSS OF THE PRINCIPAL AMOUNT INVESTED
    Bank deposit products, such as checking, savings and bank lending and related services are offered by JPMorgan Chase Bank, N.A. Member FDIC. Not a commitment to lend. All extensions of credit are subject to credit approval.